FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Devilee

Research Profile

Disorders

Genes & Molecular Sequences

Physiology

Chemicals & Drugs

Procedures

Anatomy

Chromosomes, Human, Pair 11

Co-author Network

Publications

TOP 3
Francisco Javier Gracia-Aznarez; Florentine S M Hilbers; John Hopper; Conchi Lazaro; Henry T Lynch; Siranoush Manoukian; Sylvie Mazoyer; Leticia Moreno; Fabrice Odefrey; Ana Osorio; Paolo Peterlongo; Guillermo Pita; Paolo Radice; Juan Manuel Rosa-Rosa; Olga M Sinilnikova; Melissa C Southey; Christi J van Asperen; Hans F A Vasen; Trinidad Caldes; Irene Catucci; Miguel de la Hoya; Peter Devilee; Orlando Dominguez; Mercedes Duran; Victoria Fernandez; David Goldgar; Anna Gonzalez-Neira; Javier Benitez
Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles.
Florentine S Hilbers; Nicoline Hoogerbrugge; Jeroen F J Laros; Carel Meijers; petra nederlof; Christi J van Asperen; Michiel van Galen; Hans F A Vasen; Juul T Wijnen; Peter Devilee
Exome sequencing of germline DNA from non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling.
Florentine S Hilbers; Nicoline Hoogerbrugge; Paul A James; Siranoush Manoukian; Kenneth Offit; Jan C Oosterwijk; Paolo Peterlongo; Paolo Radice; Sohela Shah; Ella R Thompson; Alison H Trainer; Christi J van Asperen; Xianshu Wang; Juul Wijnen; Javier Benitez; Ian G Campbell; Fabio Capra; Margriet J Collee; Fergus J Couch; Irene Feroce; Javier Gracia; Lucia Guidugli; Peter Devilee
Rare variants in XRCC2 as breast cancer susceptibility alleles.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Devilee (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Francisco Javier Gracia-Aznarez; Florentine S M Hilbers; John Hopper; Conchi Lazaro; Henry T Lynch; Siranoush Manoukian; Sylvie Mazoyer; Leticia Moreno; Fabrice Odefrey; Ana Osorio; Paolo Peterlongo; Guillermo Pita; Paolo Radice; Juan Manuel Rosa-Rosa; Olga M Sinilnikova; Melissa C Southey; Christi J van Asperen; Hans F A Vasen; Trinidad Caldes; Irene Catucci; Miguel de la Hoya; Peter Devilee; Orlando Dominguez; Mercedes Duran; Victoria Fernandez; David Goldgar; Anna Gonzalez-Neira; Javier Benitez
Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles.
PloS one 2013;8(2):e55681.
2013: Florentine S Hilbers; Nicoline Hoogerbrugge; Jeroen F J Laros; Carel Meijers; petra nederlof; Christi J van Asperen; Michiel van Galen; Hans F A Vasen; Juul T Wijnen; Peter Devilee
Exome sequencing of germline DNA from non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling.
PloS one 2013;8(1):e55734.
2012: Florentine S Hilbers; Nicoline Hoogerbrugge; Paul A James; Siranoush Manoukian; Kenneth Offit; Jan C Oosterwijk; Paolo Peterlongo; Paolo Radice; Sohela Shah; Ella R Thompson; Alison H Trainer; Christi J van Asperen; Xianshu Wang; Juul Wijnen; Javier Benitez; Ian G Campbell; Fabio Capra; Margriet J Collee; Fergus J Couch; Irene Feroce; Javier Gracia; Lucia Guidugli; Peter Devilee
Rare variants in XRCC2 as breast cancer susceptibility alleles.
Journal of medical genetics 2012;49(10):618-20.
2012: Heleen van der Klift; Peter Devilee; Frederik J Hes; Carli Tops; Juul T Wijnen
Insertion of an SVA element, a nonautonomous retrotransposon, in PMS2 intron 7 as a novel cause of Lynch syndrome.
Human mutation 2012;33(7):1051-5.
2012: Astrid A Out; Mieke Schutte; Caroline Seynaeve; Carli Tops; Christi J van Asperen; Ivonne J H M van Minderhout; Marijke Wasielewski; Juul T Wijnen; Frederik J Hes; Jeanine J Houwing-Duistermaat; Petra E A Huijts; Maartje Nielsen; Martijn H Breuning; Peter Devilee
MUTYH gene variants and breast cancer in a Dutch case–control study.
Breast cancer research and treatment 2012;134(1):219-27.
2012: Daniel J Park; M Pertesi; B J Pope; Sean V Tavtigian; M B Terry; H Tsimiklis; Catherine VOEGELE; Irene L Andrulis; Alicia Barroso; J Benitez; S Buys; M Daly; Peter Devilee; Graham G Giles; David E Goldgar; Fleur Hammet; F M Hilbers; N Hoogerbrugge; John L Hopper; E M John; F Le Calvez-Kelm; Fabienne LESUEUR; A Lonie; S L Neuhausen; T Nguyen-Dumont; Fabrice Odefrey; Ana Osorio; Melissa C Southey
Rare mutations in XRCC2 increase the risk of breast cancer.
American journal of human genetics 2012;90(4):734-9.
2012: Simon A Joosse; Kim I M Brandwijk; Peter Devilee; Frans B L Hogervorst; Senno Verhoef; Jelle Wesseling; petra nederlof
Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.
Breast cancer research and treatment 2012;132(2):379-89.
2011: E F Hensen; Jeroen C Jansen; Johannes A Romijn; M D Siemers; Carli Tops; Andel G L van der Mey; Jean-Pierre Bayley; C J Cornelisse; E P M Corssmit; Peter Devilee; A H J T Vriends
Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patients.
Clinical endocrinology 2011;75(5):650-5.
2011: M A Didraga; Frans B L Hogervorst; Nicoline Hoogerbrugge; S A Joosse; M J L Ligtenberg; Rogier A Oldenburg; E H van Beers; Senno Verhoef; Lodewyk F A Wessels; K I M Brandwijk; Peter Devilee; petra nederlof
A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients.
Breast cancer research and treatment 2011;130(2):425-36.
2011: Els Robanus-Maandag; Karoly Szuhai; Sabine Tejpar; Benjamin A Alman; Saeid Amini Nik; Cathy A J Bosch; Pascale Cervera; Peter Devilee; Diana Eccles; Marco Giovannini; Jeroen Knijnenburg; Raymond Poon; Paolo Radice; Riccardo Fodde
Familial adenomatous polyposis-associated desmoids display significantly more genetic changes than sporadic desmoids.
PloS one 2011;6(9):e24354.
2011: Petra E A Huijts; Wilma E Mesker; Vincent T H B M Smit; R A E M Tollenaar; Christi J van Asperen; Minka van Dongen; Adrian J van Moolenbroek; Erik W van Zwet; Maaike P G Vreeswijk; Freek Blanken; Moniek C M de Goeij; Esther M de Kruijf; Peter Devilee
Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10.
Breast cancer research : BCR 2011;13(4):R72.
2010: Aglaya G Iyevleva; Evgeny Suspitsin; Karin Kroeze; Tatiana V Gorodnova; Anna Sokolenko; Konstantin G Buslov; Dmitry A Voskresenskiy; Alexandr V Togo; Sergey P Kovalenko; Nienke van der Stoep; Peter Devilee; Evgeny N Imyanitov
Non-founder BRCA1 mutations in Russian breast cancer patients.
Cancer letters 2010;298(2):258-63.
2010: Marijke Wasielewski; Astrid A Out; Joyce Vermeulen; Maartje Nielsen; Ans van den Ouweland; Carli Tops; Juul Wijnen; Hans F A Vasen; Janneke Weiss; Jan G M Klijn; Peter Devilee; Frederik J Hes; Mieke Schutte
Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer.
Breast cancer research and treatment 2010;124(3):635-41.
2010: Nic Waddell; Jeremy Arnold; Sibylle Cocciardi; Leonard da Silva; Anna Marsh; Joan Riley; Cameron N Johnstone; Mohammed Orloff; Guillaume Assie; Charis Eng; Lynne Reid; Patricia Keith; Max Yan; Stephen Fox; Peter Devilee; Andrew K Godwin; Frans B L Hogervorst; Fergus J. Couch; Sean M Grimmond; James M Flanagan; Kumkum Khanna; Peter T Simpson; Sunil R Lakhani; Georgia Chenevix-Trench
Subtypes of familial breast tumours revealed by expression and copy number profiling.
Breast cancer research and treatment 2010;123(3):661-77.
2010: Nidia Y Cerecer-Gil; Luis Figuera; Francisco J Llamas; Mauricio Lara; José G Escamilla; Ruben Ramos; Gerardo Estrada; A Karim Hussain; José Gaal; Esther Korpershoek; Ronald R de Krijger; Winand N M Dinjens; Peter Devilee; Jean-Pierre Bayley
Mutation of SDHB is a cause of hypoxia-related high-altitude paraganglioma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(16):4148-54.
2010: Jean-Pierre Bayley; Peter Devilee
Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree?
Current opinion in genetics & development 2010;20(3):324-9.
2010: Anneke Middeldorp; Shantie C Jagmohan-Changur; Heleen van der Klift; Marjo Van Puijenbroek; Jeanine J Houwing-Duistermaat; Emily Webb; Richard Houlston; Carli Tops; Hans F A Vasen; Peter Devilee; Hans Morreau; Tom van Wezel; Juul Wijnen
Comprehensive genetic analysis of seven large families with mismatch repair proficient colorectal cancer.
Genes, chromosomes & cancer 2010;49(6):539-48.
2010: Heleen van der Klift; Carli Tops; Elsa C Bik; Merel W Boogaard; Anne-Marijke Borgstein; Kerstin B M Hansson; Margreet G E M Ausems; Encarna Gomez Garcia; Andrew Green; Frederik J Hes; Louise Izatt; Liselotte P van Hest; Angel M Alonso; Annette H J T Vriends; Anja Wagner; Wendy A G van Zelst-Stams; Hans F A Vasen; Hans Morreau; Peter Devilee; Juul Wijnen
Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of Lynch syndrome patients.
Human mutation 2010;31(5):578-87.
2010: Els C Robanus-Maandag; Pim J Koelink; Cor Breukel; Daniela C F Salvatori; Shantie C Jagmohan-Changur; Cathy A J Bosch; Hein Verspaget; Peter Devilee; Riccardo Fodde; Ron Smits
A new conditional Apc-mutant mouse model for colorectal cancer.
Carcinogenesis 2010;31(5):946-52.
2010: Jean-Pierre Bayley; Henricus P M Kunst; Alberto Cascon; Maria Lourdes Sampietro; José Gaal; Esther Korpershoek; Adolfo Hinojar-Gutierrez; Henri J L M Timmers; Lies Hoefsloot; Mario A Hermsen; Carlos Suárez; A Karim Hussain; Annette H J T Vriends; Frederik J Hes; Jeroen C Jansen; Carli M Tops; Eleonora P Corssmit; Peter de Knijff; Jacques W M Lenders; Cor W R J Cremers; Peter Devilee; Winand N M Dinjens; Ronald R de Krijger; Mercedes Robledo
SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma.
The lancet oncology 2010;11(4):366-72.
2010: Peter Devilee; Matti A Rookus
A tiny step closer to personalized risk prediction for breast cancer.
The New England journal of medicine 2010;362(11):1043-5.
2010: Neil V Morgan; Mark Morris; Hakan Cangul; Diane Gleeson; Anna Straatman-Iwanowska; Nicholas Davies; Stephen Keenan; Shanaz Pasha; Fatimah Rahman; Dean Gentle; Maaike P G Vreeswijk; Peter Devilee; Margaret A Knowles; Serdar Ceylaner; Richard C Trembath; Carlos Dalence; Erol Kismet; Vedat Köseoğlu; Hans-Christoph Rossbach; Paul Gissen; David Tannahill; Eamonn R Maher
Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease.
PLoS genetics 2010;6(2):e1000833.
2010: Erik F Hensen; Jeroen C Jansen; Maaike D Siemers; Jan C Oosterwijk; Annette Hjt Vriends; E P M Corssmit; Jean-Pierre Bayley; Andel G L van der Mey; Cees J Cornelisse; Peter Devilee
The Dutch founder mutation SDHD.D92Y shows a reduced penetrance for the development of paragangliomas in a large multigenerational family.
European journal of human genetics : EJHG 2010;18(1):62-6.
2009: Astrid A Out; Ivonne J H M van Minderhout; Jelle J Goeman; Yavuz Ariyurek; Stephan Ossowski; Korbinian Schneeberger; Detlef Weigel; Michiel van Galen; Peter E M Taschner; Carli Tops; Martijn H Breuning; Gert-Jan B van Ommen; Johan T den Dunnen; Peter Devilee; Frederik J Hes
Deep sequencing to reveal new variants in pooled DNA samples.
Human mutation 2009;30(12):1703-12.
2009: Anneke Middeldorp; Shantie Jagmohan-Changur; Ronald van Eijk; Carli Tops; Peter Devilee; Hans F A Vasen; Frederik J Hes; Richard Houlston; Ian Tomlinson; Jeanine J Houwing-Duistermaat; Juul Wijnen; Hans Morreau; Tom van Wezel
Enrichment of low penetrance susceptibility loci in a Dutch familial colorectal cancer cohort.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(11):3062-7.
2009: Juan Manuel Rosa-Rosa; Guillermo Pita; Anna González-Neira; Roger L Milne; Victoria Fernandez; Claudia Ruivenkamp; Christi J van Asperen; Peter Devilee; Javier Benitez
A 7 Mb region within 11q13 may contain a high penetrance gene for breast cancer.
Breast cancer research and treatment 2009;118(1):151-9.
2009: Jean-Pierre Bayley; Janneke Weiss; Anneliese Grimbergen; Bernadette T J van Brussel; Frederik J Hes; Jeroen C Jansen; Senno Verhoef; Peter Devilee; Eleonora P Corssmit; Annette H J T Vriends
Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
Endocrine-related cancer 2009;16(3):929-37.
2009: Huai-Xiang Hao; Oleh Khalimonchuk; Margit Schraders; Noah Dephoure; Jean-Pierre Bayley; Henricus Kunst; Peter Devilee; Cor W R J Cremers; Joshua Schiffman; Brandon G Bentz; Steven P Gygi; Dennis R Winge; Hannie Kremer; Jared Rutter
SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma.
Science (New York, N.Y.) 2009;325(5944):1139-42.
2009: Pim J Koelink; Els C Robanus-Maandag; Peter Devilee; Daniel W Hommes; Cornelis B H W Lamers; Hein Verspaget
5-Aminosalicylic acid inhibits colitis-associated but not sporadic colorectal neoplasia in a novel conditional Apc mouse model.
Carcinogenesis 2009;30(7):1217-24.
2009: Yulia M Ulybina; Ekaterina Kuligina; Nathalia V Mitiushkina; Maxim E Rozanov; Alexandr O Ivantsov; Daria N Ponomariova; Alexandr V Togo; Evgeny V Levchenko; Vladimir A Shutkin; Sergiu I Brenister; Peter Devilee; Boris Zhivotovsky; Ari Hirvonen; Evgeny N Imyanitov
Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancer.
Cancer letters 2009;278(2):183-91.
2009: Jean-Pierre Bayley; Ivonne van Minderhout; Pancras C W Hogendoorn; Cees J Cornelisse; Annemieke van der Wal; Frans A Prins; Luc Teppema; Albert Dahan; Peter Devilee; Peter E M Taschner
Sdhd and SDHD/H19 knockout mice do not develop paraganglioma or pheochromocytoma.
PloS one 2009;4(11):e7987.
2009: Ana Maria Cervera; Jean-Pierre Bayley; Peter Devilee; Kenneth J McCreath
Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells.
Molecular cancer 2009;8():89.
2009: Leila Mohammadi; Maaike P Vreeswijk; Rogier Oldenburg; Ans van den Ouweland; Jan C Oosterwijk; Annemarie H Van Der Hout; Nicoline Hoogerbrugge; M J L Ligtenberg; Margreet G E M Ausems; Rob B van der Luijt; Charlotte J Dommering; Johan J Gille; Senno Verhoef; Frans B Hogervorst; Theo A M van Os; Encarna Gómez García; Marinus J Blok; Juul Wijnen; Quinta Helmer; Peter Devilee; Christi J van Asperen; Hans C van Houwelingen
A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example.
BMC cancer 2009;9():211.
2009: Asta Björk Jonsdottir; Maaike P G Vreeswijk; Ron Wolterbeek; Peter Devilee; Hans J Tanke; Jorunn E Eyfjörd; Karoly Szuhai
BRCA2 heterozygosity delays cytokinesis in primary human fibroblasts.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2009;31(3):191-201.
2009: Erik F Hensen; Jelle J Goeman; Jan Oosting; Andel G L van der Mey; Pancras Hogendoorn; Cor W R J Cremers; Peter Devilee; Cees J Cornelisse
Similar gene expression profiles of sporadic, PGL2-, and SDHD-linked paragangliomas suggest a common pathway to tumorigenesis.
BMC medical genomics 2009;2():25.
2009: Jean-Pierre Bayley; Anneliese E M Grimbergen; Patrick A van Bunderen; Michiel van der Wielen; Henricus P Kunst; Jacques W Lenders; Jeroen C Jansen; Robin P F Dullaart; Peter Devilee; Eleonora P Corssmit; Annette H Vriends; Monique Losekoot; Janneke Weiss
The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patients.
BMC medical genetics 2009;10():34.
2009: Encarnación B Gómez García; Jan C Oosterwijk; Maarten Timmermans; Christi J van Asperen; Frans B L Hogervorst; Nicoline Hoogerbrugge; Rogier Oldenburg; Senno Verhoef; Charlotte J Dommering; Margreet G E M Ausems; Theo A M van Os; Annemarie H Van Der Hout; M J L Ligtenberg; Ans van den Ouweland; Rob B van der Luijt; Juul Wijnen; Jan J P Gille; Patrick J Lindsey; Peter Devilee; Marinus J Blok; Maaike P G Vreeswijk
A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history.
Breast cancer research : BCR 2009;11(1):R8.
2009: Juul Wijnen; Richard M Brohet; Ronald van Eijk; Shantie Jagmohan-Changur; Anneke Middeldorp; Carli Tops; Mario van Puijenbroek; Margreet G E M Ausems; Encarna Gómez García; Frederik J Hes; Nicoline Hoogerbrugge; Fred H Menko; Theo A M van Os; Rolf Sijmons; Senno Verhoef; Anja Wagner; Fokko M Nagengast; Jan H Kleibeuker; Peter Devilee; Hans Morreau; David Goldgar; Ian P M Tomlinson; richard Houlston; Tom van Wezel; H F A Vasen
Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome.
Gastroenterology 2009;136(1):131-7.
2009: Maaike P G Vreeswijk; Jaennelle N Kraan; Heleen van der Klift; Geraldine R Vink; Cees J Cornelisse; Juul Wijnen; Egbert Bakker; Christi J van Asperen; Peter Devilee
Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programs.
Human mutation 2009;30(1):107-14.
2008: Rogier A Oldenburg; Karin H G Kroeze-Jansema; Jeanine J Houwing-Duistermaat; Jean-Pierre Bayley; Cheryl Dambrot; Christi J van Asperen; Ans M W van den Ouweland; Bert Bakker; erik van beers; petra nederlof; H F A Vasen; Nicoline Hoogerbrugge; Cees J Cornelisse; Hanne Meijers-Heijboer; Peter Devilee
Genome-wide linkage scan in Dutch hereditary non-BRCA1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locus.
Genes, chromosomes & cancer 2008;47(11):947-56.
2008: Geertruida H de Bock; Catharina E Jacobi; Caroline Seynaeve; Elly M M Krol-Warmerdam; Jannet Blom; Christi J van Asperen; Cees J Cornelisse; Jan G M Klijn; Peter Devilee; Rob A E M Tollenaar; Cecile T M Brekelmans; Johannes C van Houwelingen
A family history of breast cancer will not predict female early onset breast cancer in a population-based setting.
BMC cancer 2008;8():203.
2007: Heli J Lehtonen; Markus Makinen; Maija Kiuru; Päivi Laiho; Riitta Herva; Ivonne van Minderhout; Pancras Hogendoorn; Cees J Cornelisse; Peter Devilee; Virpi Launonen; Lauri A Aaltonen
Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability.
International journal of cancer. Journal international du cancer 2007;121(6):1386-9.
2007: Evgeny N Imyanitov; Cees J Cornelisse; Peter Devilee
Searching for susceptibility alleles: emphasis on bilateral breast cancer.
International journal of cancer. Journal international du cancer 2007;121(4):921-3.
2007: Rogier A Oldenburg; Hanne Meijers-Heijboer; Cees J Cornelisse; Peter Devilee
Genetic susceptibility for breast cancer: how many more genes to be found?
Critical reviews in oncology/hematology 2007;63(2):125-49.
2007: Catharina E Jacobi; Yvette van Ierland; Christi J van Asperen; Eric Hallensleben; Peter Devilee; Gert Jan Fleuren; Gemma G Kenter
Prediction of BRCA1/2 mutation status in patients with ovarian cancer from a hospital-based cohort.
Genetics in medicine : official journal of the American College of Medical Genetics 2007;9(3):173-9.
2007: Petra E A Huijts; Maaike P G Vreeswijk; Karin H G Kroeze-Jansema; Catharina E Jacobi; Caroline Seynaeve; E M M Krol-Warmerdam; Pauline M Wijers-Koster; Jannet C Blom; Karen A Pooley; Jan G M Klijn; R A E M Tollenaar; Peter Devilee; Christi J van Asperen
Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases.
Breast cancer research : BCR 2007;9(6):R78.
2007: Anna Gonzalez-Neira; Juan Manuel Rosa-Rosa; Ana Osorio; Emilio Gonzalez; Melissa C Southey; Olga M Sinilnikova; Henry Lynch; Rogier A Oldenburg; Christi J van Asperen; Nicoline Hoogerbrugge; Guillermo Pita; Peter Devilee; David E Goldgar; Javier Benitez
Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies.
BMC genomics 2007;8():299.
2007: Anna Sokolenko; Maxim E Rozanov; Natalia V Mitiushkina; Natalia Yu Sherina; Aglaya G Iyevleva; Elena V Chekmariova; Konstantin G Buslov; Evgeny S Shilov; Alexandr V Togo; Elena M Bit-Sava; Dmitry A Voskresenskiy; Oleg L Chagunava; Peter Devilee; Cees J Cornelisse; Vladimir F Semiglazov; Evgeny N Imyanitov
Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia.
Familial cancer 2007;6(3):281-6.
2007: Anneke Middeldorp; Shantie Jagmohan-Changur; Quinta Helmer; Heleen van der Klift; Carli Tops; H F A Vasen; Peter Devilee; Hans Morreau; Jeanine J Houwing-Duistermaat; Juul Wijnen; Tom van Wezel
A procedure for the detection of linkage with high density SNP arrays in a large pedigree with colorectal cancer.
BMC cancer 2007;7():6.
2006: Elena V Chekmariova; Anna Sokolenko; Konstantin G Buslov; Aglaya G Iyevleva; Yulia M Ulibina; Maxim E Rozanov; Natalia V Mitiushkina; Alexandr V Togo; Dmitry E Matsko; Dmitry A Voskresenskiy; Oleg L Chagunava; Peter Devilee; Cees J Cornelisse; Vladimir F Semiglazov; Evgeny N Imyanitov
CHEK2 1100delC mutation is frequent among Russian breast cancer patients.
Breast cancer research and treatment 2006;100(1):99-102.
2006: Anna Sokolenko; Natalia V Mitiushkina; Konstantin G Buslov; Elena M Bit-Sava; Aglaya G Iyevleva; Elena V Chekmariova; Ekaterina Kuligina; Yulia M Ulibina; Maxim E Rozanov; Evgeny Suspitsin; Dmitry E Matsko; Oleg L Chagunava; Dmitry Yu Trofimov; Peter Devilee; Cees J Cornelisse; Alexandr V Togo; Vladimir F Semiglazov; Evgeny N Imyanitov
High frequency of BRCA1 5382insC mutation in Russian breast cancer patients.
European journal of cancer (Oxford, England : 1990) 2006;42(10):1380-4.
2006: Rogier A Oldenburg; Karin Kroeze-Jansema; Hanne Meijers-Heijboer; Christi J van Asperen; Nicoline Hoogerbrugge; Inge van Leeuwen; H F A Vasen; Anne-Marie Cleton-Jansen; Jaennelle Kraan; Jeanine J Houwing-Duistermaat; Hans Morreau; Cees J Cornelisse; Peter Devilee
Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1693-700.
2006: Geertruida H de Bock; Marian J E Mourits; Mieke Schutte; E M M Krol-Warmerdam; Caroline Seynaeve; Johanna Blom; Cecile T M Brekelmans; Hanne Meijers-Heijboer; Christi J van Asperen; Cees J Cornelisse; Peter Devilee; R A E M Tollenaar; Jan G M Klijn
Association between the CHEK2*1100delC germ line mutation and estrogen receptor status.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 2():552-5.
2006: Jean-Pierre Bayley; Ivonne van Minderhout; Janneke Weiss; Jeroen C Jansen; Peter H N Oomen; Fred H Menko; Barbara Pasini; Barbara Ferrando; Nora Wong; Lesley C Alpert; Rosie Williams; Edward Blair; Peter Devilee; Peter E M Taschner
Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
BMC medical genetics 2006;7():1.
2005: Ewa Majdak; Jaroslaw Debniak; Tomasz Milczek; Cees J Cornelisse; Peter Devilee; Janusz Emerich; Jacek Jassem; Geertruida H de Bock
Prognostic impact of BRCA1 pathogenic and BRCA1/BRCA2 unclassified variant mutations in patients with ovarian carcinoma.
Cancer 2005;104(5):1004-12.
2005: Marjo Van Puijenbroek; Christi J van Asperen; Anneke van Mil; Peter Devilee; Tom van Wezel; Hans Morreau
Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype.
The Journal of pathology 2005;206(2):198-204.
2005: Geraldine R Vink; Christi J van Asperen; Peter Devilee; Martijn H Breuning; Egbert Bakker
Unclassified variants in disease-causing genes: nonuniformity of genetic testing and counselling, a proposal for guidelines.
European journal of human genetics : EJHG 2005;13(5):525-7.
2005: Konstantin G Buslov; Aglaya G Iyevleva; Elena V Chekmariova; Evgeny Suspitsin; Alexandr V Togo; Ekaterina Kuligina; Anna Sokolenko; Dmitry E Matsko; Elena A Turkevich; Yulia R Lazareva; Oleg L Chagunava; Elena M Bit-Sava; Vladimir F Semiglazov; Peter Devilee; Cees J Cornelisse; Kaido P Hanson; Evgeny N Imyanitov
NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia.
International journal of cancer. Journal international du cancer 2005;114(4):585-9.
2005: erik van beers; Tibor van Welsem; Lodewyk F A Wessels; Yunlei Li; Rogier A Oldenburg; Peter Devilee; Cees J Cornelisse; Senno Verhoef; Frans B L Hogervorst; Laura J van't Veer; petra nederlof
Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations.
Cancer research 2005;65(3):822-7.
2005: Jean-Pierre Bayley; Peter Devilee; Peter E M Taschner
The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency.
BMC medical genetics 2005;6():39.
2005: Ewa Majdak; Geertruida H de Bock; Izabela Brozek; Magdalena Perkowska; Karolina Ochman; Jaroslaw Debniak; Tomasz Milczek; Cees J Cornelisse; Jacek Jassem; Janusz Emerich; Janusz Limon; Peter Devilee
Prevalence and clinical correlations of BRCA1/BRCA2 unclassified variant carriers among unselected primary ovarian cancer cases - preliminary report.
European journal of cancer (Oxford, England : 1990) 2005;41(1):143-50.
2005: Miguel de la Hoya; Hanne Meijers-Heijboer; Juan Manuel Fernández; Orland Díez; Ana Osorio; Carmen Alonso; Inge van Leeuwen; Eduardo Díaz-Rubio; Cees J Cornelisse; Javier Benítez; Peter Devilee; Trinidad Caldés
Mutant BRCA1 alleles transmission: different approaches and different biases.
International journal of cancer. Journal international du cancer 2005;113(1):166-7.
2004: Geertruida H de Bock; Mieke Schutte; E M M Krol-Warmerdam; C Seynaeve; Johanna Blom; Cecile T M Brekelmans; Hanne Meijers-Heijboer; Christi J van Asperen; Cees J Cornelisse; Peter Devilee; R A E M Tollenaar; Jan G M Klijn
Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant.
Journal of medical genetics 2004;41(10):731-5.
2004: Erik F Hensen; Ekaterina S. Jordanova; Ivonne van Minderhout; Pancras Hogendoorn; Peter E M Taschner; Andel G L van der Mey; Peter Devilee; Cees J Cornelisse
Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families.
Oncogene 2004;23(23):4076-83.
2004: Rogier A Oldenburg; Wouter H de Vos tot Nederveen Cappel; Marjo Van Puijenbroek; Ans M W van den Ouweland; Egbert Bakker; Gerrit Griffioen; Peter Devilee; Cees J Cornelisse; Hanne Meijers-Heijboer; H F A Vasen; Hans Morreau
Extending the p16-Leiden tumour spectrum by respiratory tract tumours.
Journal of medical genetics 2004;41(3):e31.
2004: Csilla I Szabo; Mieke Schutte; Annegien Broeks; Jeanine J Houwing-Duistermaat; Yvonne R Thorstenson; Francine Durocher; Rogier A Oldenburg; Marijke Wasielewski; Fabrice Odefrey; Deborah Thompson; Arno N Floore; Jaennelle Kraan; Jan G M Klijn; Ans M W van den Ouweland; Teresa M U Wagner; Peter Devilee; Jacques Simard; Laura J van 't Veer; David E Goldgar; Hanne Meijers-Heijboer
Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?
Cancer research 2004;64(3):840-3.
2003: Rogier A Oldenburg; Karin Kroeze-Jansema; Jaennelle Kraan; Hans Morreau; Jan G M Klijn; Nicoline Hoogerbrugge; M J L Ligtenberg; Christi J van Asperen; H F A Vasen; Carel Meijers; Hanne Meijers-Heijboer; Truuske H de Bock; Cees J Cornelisse; Peter Devilee
The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.
Cancer research 2003;63(23):8153-7.
2003: Christi J van Asperen; R A E M Tollenaar; E M M Krol-Warmerdam; Johanna Blom; WE Hoogendoorn; C M J C Seynaeve; Cecile T M Brekelmans; Peter Devilee; Cees J Cornelisse; Jan G M Klijn; Geertruida H de Bock
Possible consequences of applying guidelines to healthy women with a family history of breast cancer.
European journal of human genetics : EJHG 2003;11(8):633-6.
2003: Geertruida H de Bock; R A E M Tollenaar; Hadewych Papelard; Theodora P M Vliet Vlieland; Peter Devilee; Cornelis J Cornelisse; Jan P Vandenbroucke
Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Journal of the National Cancer Institute 2003;95(13):1011-2; author reply 1012-3.
2003: Annegien Broeks; Jos H M Urbanus; Peter de Knijff; Peter Devilee; Marion Nicke; Karin Klöpper; Thilo Dörk; Arno N Floore; Laura J van't Veer
IVS10-6T>G, an ancient ATM germline mutation linked with breast cancer.
Human mutation 2003;21(5):521-8.
2003: Peter Hohenstein; Lia Molenaar; Joyce Dijs-Elsinga; Hans Morreau; Heleen van der Klift; Ada Struijk; Shantie Jagmohan-Changur; Ron Smits; Henk J van Kranen; Gert-Jan B van Ommen; Cees J Cornelisse; Peter Devilee; Riccardo Fodde
Serrated adenomas and mixed polyposis caused by a splice acceptor deletion in the mouse Smad4 gene.
Genes, chromosomes & cancer 2003;36(3):273-82.
2002: Miguel de la Hoya; Ana Osorio; Javier Godino; Sara Sulleiro; Alicia Tosar; Pedro Perez-Segura; Cristina Fernandez; Raquel Rodríguez; Eduardo Díaz-Rubio; Javier Benítez; Peter Devilee; Trinidad Caldés
Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing.
International journal of cancer. Journal international du cancer 2002;97(4):466-71.
2001: Charis Eng; Lawrence C Brody; Teresa M U Wagner; Peter Devilee; Jan Vijg; Csilla I Szabo; Sean V Tavtigian; Katherine L Nathanson; Elaine A Ostrander; Thomas S Frank
Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1.
Journal of medical genetics 2001;38(12):824-33.
2001: Geertruida H de Bock; R A E M Tollenaar; Hadewych Papelard; Cees J Cornelisse; Peter Devilee; Marc J van de Vijver
Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients.
British journal of cancer 2001;85(9):1347-50.
2001: Leon C Verhoog; Ans M W van den Ouweland; Petronella Berns; M M van Veghel-Plandsoen; Iris L van Staveren; A Wagner; C C M Bartels; Madeleine M A Tilanus-Linthorst; Peter Devilee; Caroline Seynaeve; D J Halley; Martinus F Niermeijer; Jan G M Klijn; Hanne Meijers-Heijboer
Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families.
European journal of cancer (Oxford, England : 1990) 2001;37(16):2082-90.
2001: Litanja N Lodder; Petra G Frets; Rutger W Trijsburg; Aad Tibben; E Johanna Meijers-Heijboer; Hugo J Duivenvoorden; Anja Wagner; Conny A van der Meer; Peter Devilee; Cees J Cornelisse; Martinus F Niermeijer
Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
European journal of human genetics : EJHG 2001;9(7):492-500.
2001: Peter E M Taschner; Jeroen C Jansen; Bora E Baysal; A Bosch; Efraim H. Rosenberg; Annette H J T Bröcker-Vriends; Andel G L van der Mey; Gert-Jan B van Ommen; Cees J Cornelisse; Peter Devilee
Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene.
Genes, chromosomes & cancer 2001;31(3):274-81.
2001: Peter Hohenstein; Menno F Kielman; Cor Breukel; L M Bennett; R Wiseman; Paul Krimpenfort; Cees J Cornelisse; Gert-Jan B van Ommen; Peter Devilee; Riccardo Fodde
A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage.
Oncogene 2001;20(20):2544-50.
2001: M van der Looij; J Papp; M Sztán; T Pulay; I Elfadil; I Besznyak; J Tóth; Peter Devilee; Edith Oláh
Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors.
International journal of oncology 2001;18(4):775-80.
2001: Bora E Baysal; Joan E Willett-Brozick; Peter E M Taschner; Johannes G Dauwerse; Peter Devilee; Bernie Devlin
A high-resolution integrated map spanning the SDHD gene at 11q23: a 1.1-Mb BAC contig, a partial transcript map and 15 new repeat polymorphisms in a tumour-suppressor region.
European journal of human genetics : EJHG 2001;9(2):121-9.
2001: I Stec; Marcel van Vliet; Ronald van Eijk; H Meijers; K H Kroeze; Johannes G Dauwerse; Gert-Jan B van Ommen; Cees J Cornelisse; Johan T den Dunnen; Peter Devilee
A partial BRCA1 sequence homology mapping to 4q28.
Cytogenetics and cell genetics 2001;94(1-2):26-9.
2000: T Peelen; Wiljo J F De Leeuw; K van Lent; Hans Morreau; Ronald van Eijk; Marcel van Vliet; Juul Wijnen; M J L Ligtenberg; HB Ginjaar; R Zweemer; Fred H Menko; Riccardo Fodde; Gert-Jan B van Ommen; H F A Vasen; Cees J Cornelisse; Peter Devilee
Genetic analysis of a breast-ovarian cancer family, with 7 cases of colorectal cancer linked to BRCA1, fails to support a role for BRCA1 in colorectal tumorigenesis.
International journal of cancer. Journal international du cancer 2000;88(5):778-82.
2000: Hadewych Papelard; Geertruida H de Bock; Ronald van Eijk; Theodora P M Vliet Vlieland; Cees J Cornelisse; Peter Devilee; R A E M Tollenaar
Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients.
British journal of cancer 2000;83(6):719-24.
2000: Nazneen Rahman; MD Teare; Sheila Seal; Helene Renard; J Mangion; C Cour; D Thompson; Yin Yao Shugart; Diana Eccles; Peter Devilee; H Meijers; Katherine L Nathanson; Susan L Neuhausen; B Weber; Jenny Chang-Claude; Douglas F Easton; David E Goldgar; Michael R Stratton
Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22.
Oncogene 2000;19(36):4170-3.
2000: E Johanna Meijers-Heijboer; Leon C Verhoog; Cecile T M Brekelmans; Caroline Seynaeve; Madeleine M A Tilanus-Linthorst; Anja Wagner; L Dukel; Peter Devilee; Ans M W van den Ouweland; Albertus N van Geel; Jan G M Klijn
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.
Lancet 2000;355(9220):2015-20.
2000: BA Bonsing; Willem E Corver; Gert Jan Fleuren; Anne-Marie Cleton-Jansen; Peter Devilee; Cees J Cornelisse
Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastases.
Genes, chromosomes & cancer 2000;28(2):173-83.
2000: M van der Looij; C Szabo; I Besznyak; G Liszka; B Csokay; T Pulay; J Toth; Peter Devilee; Mary-Claire King; Edith Olah
Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.
International journal of cancer. Journal international du cancer 2000;86(5):737-40.
2000: Petronella Berns; John A Foekens; Rolf H A M Vossen; Maxime P Look; Peter Devilee; SC Henzen-Logmans; Iris L van Staveren; Wim L J van Putten; M Inganäs; Marion E Meijer-Van Gelder; C Cornelisse; CJ Claassen; Henk Portengen; B Bakker; Jan G M Klijn
Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.
Cancer research 2000;60(8):2155-62.
2000: M van der Looij; Anne-Marie Cleton-Jansen; Ronald van Eijk; Hans Morreau; Marcel van Vliet; Nel J Kuipers-Dijkshoorn; Edith Oláh; Cees J Cornelisse; Peter Devilee
A sporadic breast tumor with a somatically acquired complex genomic rearrangement in BRCA1.
Genes, chromosomes & cancer 2000;27(3):295-302.
2000: Bora E Baysal; Robert E Ferrell; Joan E Willett-Brozick; Elizabeth C Lawrence; D Myssiorek; A Bosch; Andel G L van der Mey; Peter E M Taschner; Wendy S Rubinstein; Eugene N Myers; CW Richard; Cees J Cornelisse; Peter Devilee; Bernie Devlin
Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.
Science (New York, N.Y.) 2000;287(5454):848-51.
2000: Annegien Broeks; Jos H M Urbanus; Arno N Floore; Ellen C Dahler; Jan G M Klijn; E J Th Rutgers; Peter Devilee; Nicola S Russell; Flora E van Leeuwen; Laura J van 't Veer
ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.
American journal of human genetics 2000;66(2):494-500.
2000: T Peelen; Marcel van Vliet; A Bosch; G Bignell; H F A Vasen; Jan G M Klijn; Hanne Meijers-Heijboer; Michael Stratton; Gert-Jan B van Ommen; Cees J Cornelisse; Peter Devilee
Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families.
British journal of cancer 2000;82(1):151-6.
1999: HJ van Slooten; Marc J van de Vijver; A L Borresen; Jorunn E Eyfjörd; Rut Valgardsdottir; Siegfried Scherneck; J M Nesland; Peter Devilee; Cees J Cornelisse; Jan Hein van Dierendonck
Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma.
The Journal of pathology 1999;189(4):504-13.
1999: Litanja N Lodder; Petra G Frets; Rutger W Trijsburg; E Johanna Meijers-Heijboer; Jan G M Klijn; Hugo J Duivenvoorden; Aad Tibben; Anja Wagner; Conny A van der Meer; Peter Devilee; Cees J Cornelisse; Martinus F Niermeijer
Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.
Journal of medical genetics 1999;36(12):906-13.
1999: Leon C Verhoog; Cecile T M Brekelmans; Caroline Seynaeve; G Dahmen; Albertus N van Geel; C C M Bartels; Madeleine M A Tilanus-Linthorst; A Wagner; Peter Devilee; D J Halley; Ans M W van den Ouweland; E Johanna Meijers-Heijboer; Jan G M Klijn
Survival in hereditary breast cancer associated with germline mutations of BRCA2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(11):3396-402.
1999: Yin Yao Shugart; C Cour; Helene Renard; G Lenoir; David E Goldgar; Dawn M Teare; Douglas Easton; Nazneen Rahman; R Gusterton; Sheila Seal; Rita Barfoot; Michael Stratton; J Mangion; T Peelen; Ans M W van den Ouweland; H Meijers; Peter Devilee; Diana Eccles; H Lynch; B Weber; D Stoppa-Lyonnet; Y J Bignon; Jenny Chang-Claude
Linkage analysis of 56 multiplex families excludes the Cowden disease gene PTEN as a major contributor to familial breast cancer.
Journal of medical genetics 1999;36(9):720-1.
1999: EM van Schothorst; D E Prins; Bora E Baysal; Marian Beekman; Jonathan D Licht; S Waxman; Arthur Zelent; Cees J Cornelisse; Gert-Jan B van Ommen; CW Richard; Peter Devilee
Genomic structure of the human PLZF gene.
Gene 1999;236(1):21-4.
1999: Bora E Baysal; EM van Schothorst; JE Farr; P Grashof; D Myssiorek; Wendy S Rubinstein; Peter E M Taschner; Cees J Cornelisse; Bernie Devlin; Peter Devilee; CW Richard
Repositioning the hereditary paraganglioma critical region on chromosome band 11q23.
Human genetics 1999;104(3):219-25.
1999: M J L Ligtenberg; Frans B L Hogervorst; H W Willems; PJ Arts; G Brink; S Hageman; E A Bosgoed; E van der Looij; Matti A Rookus; Peter Devilee; E M Vos; G Wigbout; P M Struycken; Fred H Menko; E J Th Rutgers; Lies Hoefsloot; E C Mariman; Han G Brunner; Laura J van 't Veer
Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2.
British journal of cancer 1999;79(9-10):1475-8.
1998: EM van Schothorst; Marian Beekman; P Torremans; Nel J Kuipers-Dijkshoorn; Hans W Wessels; A F Bardoel; Andel G L van der Mey; M J van der Vijver; Gert-Jan B van Ommen; Peter Devilee; Cees J Cornelisse
Paragangliomas of the head and neck region show complete loss of heterozygosity at 11q22-q23 in chief cells and the flow-sorted DNA aneuploid fraction.
Human pathology 1998;29(10):1045-9.
1998: EM van Schothorst; Jeroen C Jansen; Edward Grooters; D E Prins; J J Wiersinga; Andel G L van der Mey; Gert-Jan B van Ommen; Peter Devilee; Cees J Cornelisse
Founder effect at PGL1 in hereditary head and neck paraganglioma families from the Netherlands.
American journal of human genetics 1998;63(2):468-73.
1998: Teresa M U Wagner; RA Möslinger; Daniela Muhr; Gudrun Langbauer; Kora Hirtenlehner; H Concin; W Doeller; Anton Haid; A H Lang; P Mayer; E Ropp; Ernst Kubista; B Amirimani; Thomas Helbich; Alexander Becherer; Otto Scheiner; Heimo Breiteneder; A Borg; Peter Devilee; Peter Oefner; Christoph Zielinski
BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics.
International journal of cancer. Journal international du cancer 1998;77(3):354-60.
1998: Susan L Neuhausen; A K Godwin; R Gershoni-Baruch; E Schubert; Judy E Garber; D Stoppa-Lyonnet; Edith Olah; B Csokay; OM Serova; Fiona Lalloo; A Osorio; Michael Stratton; Kenneth Offit; J Boyd; MA Caligo; R J Scott; A Schofield; E Teugels; M Schwab; Lisa A Cannon-Albright; D Timothy Bishop; Douglas Easton; J Benitez; Mary-Claire King; Bruce A J Ponder; B Weber; Peter Devilee; Ake Borg; Steven A Narod; David E Goldgar
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.
American journal of human genetics 1998;62(6):1381-8.
1998: D Ford; Douglas F Easton; Michael Stratton; Steven A Narod; David E Goldgar; Peter Devilee; Tim BISHOP; B Weber; G Lenoir; Jenny Chang-Claude; H Sobol; MD Teare; Jeffery Struewing; Adalgeir Arason; Siegfried Scherneck; Julian Peto; T R Rebbeck; P Tonin; Susan L Neuhausen; Rosa B Barkardottir; Jorunn E Eyfjord; H Lynch; Bruce A J Ponder; Simon A Gayther; M Zelada-Hedman
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
American journal of human genetics 1998;62(3):676-89.
1998: Leon C Verhoog; Cecile T M Brekelmans; Caroline Seynaeve; L M van den Bosch; G Dahmen; Albertus N van Geel; Madeleine M A Tilanus-Linthorst; C C M Bartels; A Wagner; Ans M W van den Ouweland; Peter Devilee; E Johanna Meijers-Heijboer; Jan G M Klijn
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.
Lancet 1998;351(9099):316-21.
1997: A Petrij-Bosch; T Peelen; Marcel van Vliet; Ronald van Eijk; R Olmer; M Drüsedau; Frans B L Hogervorst; S Hageman; PJ Arts; M J L Ligtenberg; Hanne Meijers-Heijboer; Jan G M Klijn; H F A Vasen; Cees J Cornelisse; Laura J van 't Veer; Egbert Bakker; Gert-Jan B van Ommen; Peter Devilee
BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients.
Nature genetics 1997;17(3):341-5.
1997: Cees J Cornelisse; Peter Devilee
Facts in cancer genetics.
Patient education and counseling 1997;32(1-2):9-17.
1997: Bora E Baysal; EM van Schothorst; JE Farr; MR James; Peter Devilee; CW Richard
A high-resolution STS, EST, and gene-based physical map of the hereditary paraganglioma region on chromosome 11q23.
Genomics 1997;44(2):214-21.
1997: AC DudokdeWit; Aad Tibben; Petra G Frets; E Johanna Meijers-Heijboer; Peter Devilee; Jan G M Klijn; J C Oosterwijk; Martinus F Niermeijer
BRCA1 in the family: a case description of the psychological implications.
American journal of medical genetics 1997;71(1):63-71.
1997: T Peelen; Marcel van Vliet; A Petrij-Bosch; R Mieremet; C Szabo; Ans M W van den Ouweland; Frans B L Hogervorst; Richard Brohet; M J L Ligtenberg; E Teugels; Rob B van der Luijt; Annemarie H Van Der Hout; Johan J P Gille; Gerard Pals; Inge Jedema; R Olmer; Inge van Leeuwen; B Newman; M Plandsoen; M van der Est; G Brink; S Hageman; PJ Arts; M M Bakker; Peter Devilee
A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families.
American journal of human genetics 1997;60(5):1041-9.
1997: Peter Devilee; J Hermans; Jorunn E Eyfjörd; A L Bøorresen; Rosette Lidereau; H Sobol; Ake Borg; Anne-Marie Cleton-Jansen; Edith Oláh; B B Cohen; Siegfried Scherneck; U Hamann; B Peterlin; MA Caligo; Y J Bignon; Christine Maugard
Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics Consortium.
Genes, chromosomes & cancer 1997;18(3):193-9.
1997: R S Cornelis; Marcel van Vliet; M J van de Vijver; H F A Vasen; P A Voute; B Top; PM Khan; Peter Devilee; Cees J Cornelisse
Three germline mutations in the TP53 gene.
Human mutation 1997;9(2):157-63.
1996: Cees J Cornelisse; R S Cornelis; Peter Devilee
Genes responsible for familial breast cancer.
Pathology, research and practice 1996;192(7):684-93.
1996: Jan C Oosterwijk; Jeroen C Jansen; EM van Schothorst; A W Oosterhof; Peter Devilee; Egbert Bakker; Moniek W Zoeteweij; Andel G L van der Mey
First experiences with genetic counselling based on predictive DNA diagnosis in hereditary glomus tumours (paragangliomas).
Journal of medical genetics 1996;33(5):379-83.
1996: CM Phelan; Timothy R Rebbeck; Barbara L Weber; Peter Devilee; M H Ruttledge; H T Lynch; Gilbert M Lenoir; Michael R Stratton; D F Easton; Bruce A J Ponder; Lisa A Cannon-Albright; Catharina Larsson; D E Goldgar; Steven A Narod
Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.
Nature genetics 1996;12(3):309-11.
1996: EM van Schothorst; Jeroen C Jansen; A F Bardoel; Andel G L van der Mey; M J James; H Sobol; J Weissenbach; Gert-Jan B van Ommen; Cees J Cornelisse; Peter Devilee
Confinement of PGL, an imprinted gene causing hereditary paragangliomas, to a 2-cM interval on 11q22-q23 and exclusion of DRD2 and NCAM as candidate genes.
European journal of human genetics : EJHG 1996;4(5):267-73.
1996: T Peelen; R S Cornelis; Marcel van Vliet; A Petrij-Bosch; Anne-Marie Cleton-Jansen; H Meijers-Heijboer; J G Klijn; H F A Vasen; Cees J Cornelisse; Peter Devilee
The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2.
European journal of human genetics : EJHG 1996;4(4):225-30.
1995: S Friend; A L Borresen; L Brody; G Casey; Peter Devilee; S Gayther; David E Goldgar; P Murphy; B L Weber; R Wiseman
Breast cancer information on the web.
Nature genetics 1995;11(3):238-9.
1995: Anne-Marie Cleton-Jansen; N Collins; S R Lakhani; J Weissenbach; Peter Devilee; Cees J Cornelisse; Michael R Stratton
Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.
British journal of cancer 1995;72(5):1241-4.
1995: Steven A Narod; D Ford; Peter Devilee; Rosa B Barkardottir; J Eyfjord; G Lenoir; OM Serova; Douglas Easton; David E Goldgar
Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium.
American journal of human genetics 1995;57(4):957-8.
1995: Jan G M Klijn; Peter Devilee; Albertus N van Geel; Madeleine M A Tilanus-Linthorst; C Dudok-de Wit; E Johanna Meijers-Heijboer
[Initial Dutch results with a presymptomatic DNA tests in familial breast/ovarian carcinoma. Rotterdamse Werkgroep voor Erfelijke Tumoren].
Nederlands tijdschrift voor geneeskunde 1995;139(9):439-45.
1995: J C Oosterwijk; Peter Devilee; E Johanna Meijers-Heijboer; Fred H Menko; Jan G M Klijn; Cees J Cornelisse
[Cloning of the first gene for breast/ovarian cancer (BRCA1), mapping of a second gene locus (BRCA2) and consequences for clinical practice].
Nederlands tijdschrift voor geneeskunde 1995;139(9):421-3.
1995: Anne-Marie Cleton-Jansen; H W Moerland; David F Callen; Norman A Doggett; Peter Devilee; Cees J Cornelisse
Mapping of the breast basic conserved gene (D16S444E) to human chromosome band 16q24.3.
Cytogenetics and cell genetics 1995;68(1-2):49-51.
1995: Steven A Narod; D Ford; Peter Devilee; Rosa B Barkardottir; Henry T Lynch; S A Smith; B A Ponder; B L Weber; Judy E Garber; J M Birch
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.
American journal of human genetics 1995;56(1):254-64.
1994: Peter Devilee; Cees J Cornelisse
Somatic genetic changes in human breast cancer.
Biochimica et biophysica acta 1994;1198(2-3):113-30.
1994: R S Cornelis; C J Cornelisse; Peter Devilee
Selection of families for predictive testing for breast cancer.
Lancet 1994;344(8930):1151.
1994: Peter Devilee; EM van Schothorst; A F Bardoel; BA Bonsing; Nel J Kuipers-Dijkshoorn; MR James; Gert Jan Fleuren; Andel G L van der Mey; Cees J Cornelisse
Allelotype of head and neck paragangliomas: allelic imbalance is confined to the long arm of chromosome 11, the site of the predisposing locus PGL.
Genes, chromosomes & cancer 1994;11(2):71-8.
1994: R S Cornelis; Marcel van Vliet; CB Vos; Anne-Marie Cleton-Jansen; Marc J van de Vijver; Johannes L Peterse; PM Khan; A L Børresen; Cees J Cornelisse; Peter Devilee
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cancer research 1994;54(15):4200-6.
1994: A C de Wit; E Johanna Meijers-Heijboer; Aad Tibben; Petra G Frets; Jan G M Klijn; Peter Devilee; Martinus F Niermeijer
Effect on a Dutch family of predictive DNA-testing for hereditary breast and ovarian cancer.
Lancet 1994;344(8916):197.
1994: Michael R Stratton; D Ford; S Neuhasen; Sheila Seal; Richard Wooster; L S Friedman; Mary-Claire King; V Egilsson; Peter Devilee; Ross McManus
Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q.
Nature genetics 1994;7(1):103-7.
1994: Anne-Marie Cleton-Jansen; Elna W Moerland; Nel J Kuipers-Dijkshoorn; David F Callen; G R Sutherland; B Hansen; Peter Devilee; Cees J Cornelisse
At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer.
Genes, chromosomes & cancer 1994;9(2):101-7.
1994: Anne-Marie Cleton-Jansen; H W Moerland; R H Vossen; David F Callen; Martijn H Breuning; Peter Devilee
Dinucleotide repeat polymorphism at D16S533.
Human molecular genetics 1994;3(1):216.
1994: Peter Devilee; Ed Schuuring; Marc J van de Vijver; C J Cornelisse
Recent developments in the molecular genetic understanding of breast cancer.
Critical reviews in oncogenesis 1994;5(2-3):247-70.
1993: BA Bonsing; Peter Devilee; Anne-Marie Cleton-Jansen; Nel J Kuipers-Dijkshoorn; Gert Jan Fleuren; Cees J Cornelisse
Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas.
Cancer research 1993;53(16):3804-11.
1993: Nelleke A Gruis; Edwin Abeln; A F Bardoel; Peter Devilee; Rune R Frants; Cees J Cornelisse
PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumour tissue.
British journal of cancer 1993;68(2):308-13.
1993: Peter Devilee; R S Cornelis; A Bootsma; A Bardoel; Marcel van Vliet; Inge van Leeuwen; F J Cleton; A de Klein; Dick Lindhout; H F A Vasen
Linkage to markers for the chromosome region 17q12-q21 in 13 Dutch breast cancer kindreds.
American journal of human genetics 1993;52(4):730-5.
1993: R S Cornelis; Peter Devilee; Marcel van Vliet; Nel J Kuipers-Dijkshoorn; A Kersenmaeker; A Bardoel; PM Khan; Cees J Cornelisse
Allele loss patterns on chromosome 17q in 109 breast carcinomas indicate at least two distinct target regions.
Oncogene 1993;8(3):781-5.
1992: Ed Schuuring; Els Verhoeven; H van Tinteren; Johannes L Peterse; B Nunnink; F B Thunnissen; Peter Devilee; C J Cornelisse; Marc J van de Vijver; Wolter J Mooi
Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer.
Cancer research 1992;52(19):5229-34.
1992: Leendert H J Looijenga; J Wolter Oosterhuis; Vincent T H B M Smit; J W Wessels; Paul Mollevanger; Peter Devilee
Alpha satellite DNAs on chromosomes 10 and 12 are both members of the dimeric suprachromosomal subfamily, but display little identity at the nucleotide sequence level.
Genomics 1992;13(4):1125-32.
1992: Cees J Cornelisse; Nel J Kuipers-Dijkshoorn; Marcel van Vliet; J Hermans; Peter Devilee
Fractional allelic imbalance in human breast cancer increases with tetraploidization and chromosome loss.
International journal of cancer. Journal international du cancer 1992;50(4):544-8.
1991: Peter Devilee; Marcel van Vliet; Kathleen R Cho; Bert Vogelstein
HindIII polymorphism in the DCC gene.
Nucleic acids research 1991;19(24):6965.
1991: Peter Devilee; Marcel van Vliet; Petra P H Van Sloun; Nel J Kuipers-Dijkshoorn; J Hermans; P L Pearson; Cees J Cornelisse
Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q.
Oncogene 1991;6(9):1705-11.
1991: Vincent T H B M Smit; J W Wessels; Paul Mollevanger; J G Dauwerse; Marcel van Vliet; Geoffrey C Beverstock; Martijn H Breuning; Peter Devilee; Anton K Raap; Cees J Cornelisse
Improved interpretation of complex chromosomal rearrangements by combined GTG banding and in situ suppression hybridization using chromosome-specific libraries and cosmid probes.
Genes, chromosomes & cancer 1991;3(4):239-48.
1991: Peter Devilee; M van den Broek; marcel mannens; Rosalyn Slater; Cees J Cornelisse; Andries Westerveld; PM Khan
Differences in patterns of allelic loss between two common types of adult cancer, breast and colon carcinoma, and Wilms' tumor of childhood.
International journal of cancer. Journal international du cancer 1991;47(6):817-21.
1991: Peter Devilee; Marcel van Vliet; Nel J Kuipers-Dijkshoorn; P L Pearson; Cees J Cornelisse
Somatic genetic changes on chromosome 18 in breast carcinomas: is the DCC gene involved?
Oncogene 1991;6(2):311-5.
1991: Peter Devilee; Marcel van Vliet; A Bardoel; T Kievits; Nel J Kuipers-Dijkshoorn; P L Pearson; Cees J Cornelisse
Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma.
Cancer research 1991;51(3):1020-5.
1990: marcel mannens; Peter Devilee; Jet Bliek; I Mandjes; Jan de Kraker; Christa Heyting; R M Slater; Andries Westerveld
Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome 11.
Cancer research 1990;50(11):3279-83.
1990: T Kievits; J G Dauwerse; Joop Wiegant; Peter Devilee; Martijn H Breuning; Cees J Cornelisse; Gert-Jan B van Ommen; P L Pearson
Rapid subchromosomal localization of cosmids by nonradioactive in situ hybridization.
Cytogenetics and cell genetics 1990;53(2-3):134-6.
1990: T Kievits; Peter Devilee; Joop Wiegant; M C Wapenaar; Cees J Cornelisse; Gert-Jan B van Ommen; P L Pearson
Direct nonradioactive in situ hybridization of somatic cell hybrid DNA to human lymphocyte chromosomes.
Cytometry 1990;11(1):105-9.
1990: Leendert H J Looijenga; Vincent T H B M Smit; J W Wessels; Paul Mollevanger; J Wolter Oosterhuis; Cees J Cornelisse; Peter Devilee
Localization and polymorphism of a chromosome 12-specific alpha satellite DNA sequence.
Cytogenetics and cell genetics 1990;53(4):216-8.
1990: Peter Devilee; Cees J Cornelisse; Nel J Kuipers-Dijkshoorn; C Jonker; P L Pearson
Loss of heterozygosity on 17p in human breast carcinomas: defining the smallest common region of deletion.
Cytogenetics and cell genetics 1990;53(1):52-4.
1989: Peter Devilee; M van den Broek; Nel J Kuipers-Dijkshoorn; R Kolluri; PM Khan; P L Pearson; Cees J Cornelisse
At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma.
Genomics 1989;5(3):554-60.
1988: Peter Devilee; R F Thierry; T Kievits; R Kolluri; Anton H N Hopman; H F Willard; P L Pearson; Cees J Cornelisse
Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes.
Cancer research 1988;48(20):5825-30.
1988: Peter Devilee; T Kievits; J S Waye; P L Pearson; H F Willard
Chromosome-specific alpha satellite DNA: isolation and mapping of a polymorphic alphoid repeat from human chromosome 10.
Genomics 1988;3(1):1-7.